Enimmune corporation(TW:6564)
NT$14.90+-0.05 (+8.36%)
TW:6564
Enimmune corporation financials statements
NT$14.90
At close:+-0.05 (+8.36%)
Enimmune corporation (6564) Ratios
Enimmune corporation Ratios
TW:6564's free cash flow for Q2 2026 was NT$-40.93M. For the 2026 fiscal year, TW:6564's free cash flow was increased by NT$0.00 and operating cash flow was NT$-40.93M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.16 | 2.45 | 2.71 | 6.04 | 13.89 |
| Quick Ratio | 1.08 | 2.36 | 2.49 | 5.46 | 12.39 |
| Cash Ratio | 0.74 | 2.02 | 2.10 | 3.79 | 3.40 |
| Solvency Ratio | -0.51 | -0.61 | -1.25 | -2.18 | -0.96 |
| Operating Cash Flow Ratio | -0.52 | -0.60 | -0.80 | -1.93 | -2.05 |
| Short-Term Operating Cash Flow Coverage | -1.06 | -1.41 | -3.28 | -9.06 | -34.23 |
| Net Current Asset Value | NT$ 11.77M | NT$ 343.55M | NT$ 291.75M | NT$ 518.19M | NT$ 443.51M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.38 | 0.15 | 0.08 | 0.04 | 0.01 |
| Debt-to-Equity Ratio | 1.14 | 0.29 | 0.14 | 0.05 | 0.01 |
| Debt-to-Capital Ratio | 0.53 | 0.22 | 0.12 | 0.05 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.16 | 0.01 | 0.00 | 0.01 | 0.01 |
| Financial Leverage Ratio | 3.05 | 1.93 | 1.88 | 1.42 | 1.07 |
| Debt Service Coverage Ratio | -1.27 | -1.49 | -5.31 | -11.51 | -16.59 |
| Interest Coverage Ratio | -46.16 | -68.70 | -249.21 | -909.26 | -260.76 |
| Debt to Market Cap | 0.11 | 0.06 | 0.02 | 0.01 | 0.00 |
| Interest Debt Per Share | 2.43 | 1.54 | 0.71 | 0.47 | 0.14 |
| Net Debt to EBITDA | 0.18 | 2.42 | 1.37 | 1.41 | 2.87 |
| Profitability Margins | |||||
| Gross Profit Margin | 16.63% | 35.64% | -53.74% | 11.06% | 35.26% |
| EBIT Margin | -384.37% | -409.30% | -544.24% | -141.59% | -42.82% |
| EBITDA Margin | -365.54% | -390.27% | -526.42% | -137.16% | -34.96% |
| Operating Profit Margin | -384.37% | -379.02% | -559.79% | -152.01% | -53.42% |
| Pretax Profit Margin | -341.41% | -414.81% | -546.49% | -141.75% | -43.02% |
| Net Profit Margin | -341.41% | -394.70% | -514.42% | -131.60% | -43.02% |
| Continuous Operations Profit Margin | -341.41% | -414.81% | -546.49% | -141.75% | -43.02% |
| Net Income Per EBT | 100.00% | 95.15% | 94.13% | 92.84% | 100.00% |
| EBT Per EBIT | 88.82% | 109.44% | 97.62% | 93.25% | 80.53% |
| Return on Assets (ROA) | -36.07% | -21.77% | -36.99% | -31.99% | -7.74% |
| Return on Equity (ROE) | -109.92% | -42.12% | -69.50% | -45.54% | -8.29% |
| Return on Capital Employed (ROCE) | -101.56% | -31.26% | -56.21% | -42.68% | -10.20% |
| Return on Invested Capital (ROIC) | -57.73% | -25.77% | -51.03% | -41.21% | -10.15% |
| Return on Tangible Assets | -46.09% | -25.43% | -45.15% | -37.53% | -9.63% |
| Earnings Yield | -11.08% | -8.85% | -9.09% | -6.34% | -2.01% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.27 | 3.11 | 3.52 | 33.06 | 4.62 |
| Payables Turnover | 14.09 | 8.89 | 3.70 | 42.21 | 6.86 |
| Inventory Turnover | 1.89 | 1.15 | 1.78 | 2.77 | 1.37 |
| Fixed Asset Turnover | 3.41 | 10.35 | 7.40 | 22.11 | 18.56 |
| Asset Turnover | 0.11 | 0.06 | 0.07 | 0.24 | 0.18 |
| Working Capital Turnover Ratio | 0.25 | 0.12 | 0.11 | 0.39 | 0.23 |
| Cash Conversion Cycle | 278.69 | 393.75 | 210.42 | 134.12 | 292.81 |
| Days of Sales Outstanding | 111.78 | 117.45 | 103.56 | 11.04 | 79.05 |
| Days of Inventory Outstanding | 192.82 | 317.36 | 205.46 | 131.73 | 266.95 |
| Days of Payables Outstanding | 25.91 | 41.06 | 98.59 | 8.65 | 53.19 |
| Operating Cycle | 304.60 | 434.81 | 309.01 | 142.77 | 346.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.99 | -2.01 | -2.10 | -3.14 | -1.19 |
| Free Cash Flow Per Share | -2.05 | -2.02 | -2.10 | -3.14 | -1.25 |
| Dividend Paid and CapEx Coverage Ratio | -34.36 | -303.97 | 0.00 | -578.20 | -20.99 |
| Capital Expenditure Coverage Ratio | -34.36 | -303.97 | 0.00 | -578.20 | -20.99 |
| Operating Cash Flow Coverage Ratio | -0.84 | -1.33 | -3.02 | -6.76 | -8.85 |
| Operating Cash Flow to Sales Ratio | -2.98 | -3.60 | -3.18 | -1.06 | -0.65 |
| Free Cash Flow Yield | -9.95% | -8.10% | -5.61% | -5.14% | -3.19% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -9.04 | -11.32 | -11.00 | -15.75 | -49.42 |
| Price-to-Sales (P/S) Ratio | 30.81 | 44.62 | 56.59 | 20.75 | 21.40 |
| Price-to-Book (P/B) Ratio | 9.92 | 4.76 | 7.64 | 7.18 | 4.12 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.05 | -12.35 | -17.82 | -19.45 | -31.35 |
| Price-to-Operating Cash Flow Ratio | -10.35 | -12.39 | -17.82 | -19.48 | -32.85 |
| Price-to-Earnings Growth (PEG) Ratio | -2.48 | 0.32 | 0.89 | -0.04 | 1.14 |
| Enterprise Value Multiple | -8.25 | -9.01 | -9.38 | -13.72 | -58.34 |
| Enterprise Value | 1.45B | 1.40B | 2.15B | 3.54B | 2.24B |
| EV to EBITDA | -8.25 | -9.01 | -9.38 | -13.72 | -58.34 |
| EV to Sales | 30.16 | 35.17 | 49.36 | 18.81 | 20.40 |
| EV to Free Cash Flow | -9.84 | -9.73 | -15.54 | -17.64 | -29.88 |
| EV to Operating Cash Flow | -10.13 | -9.76 | -15.54 | -17.67 | -31.31 |
| Tangible Book Value Per Share | 0.70 | 5.24 | 4.89 | 8.61 | 7.48 |
| Shareholders’ Equity Per Share | 2.08 | 5.23 | 4.89 | 8.51 | 9.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.67 | 0.56 | 0.66 | 2.95 | 1.82 |
| Net Income Per Share | -2.28 | -2.20 | -3.40 | -3.88 | -0.78 |
| Tax Burden | 1.00 | 0.95 | 0.94 | 0.93 | 1.00 |
| Interest Burden | 0.89 | 1.01 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 2.33 | 2.13 | 3.20 | 1.31 | 0.50 |
| SG&A to Revenue | 1.49 | 2.02 | 1.85 | 0.29 | 0.39 |
| Stock-Based Compensation to Revenue | 0.00 | 0.08 | 0.08 | 0.01 | 0.00 |
| Income Quality | 0.87 | 0.87 | 0.58 | 0.75 | 1.51 |
Currency in TWD
